ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.

Menlo Park, CA & Dallas, TX
Joined October 2020
ReCode Therapeutics retweeted
Congrats to @ReCodeTx on the successful closing of their $80 million Series B financing! Excited to support ReCode as they advance their novel LNP platform, which has the potential to reach a broad spectrum of diseases involving multiple organs and tissue. #biotech #vidaportfolio
At ReCode, we’re working to unleash the power #genetic medicines for underserved patients with life-limiting #respiratory diseases. We're pleased to announce our raise of an $80 million #SeriesB financing to help execute this goal. Learn more here: bit.ly/rtxsrsb #RNA
1
4
ReCode Therapeutics retweeted
Congratulations to @ReCodeTx for closing $80M in Series B funding to expand its drug pipeline for respiratory diseases! Financing co-led by Pfizer Ventures and EcoR1 Capital, joined by MPM as well as other world class syndicate partners. #Biotechnology
1
1
4
What are the benefits of #mRNA technology in #vaccines? @PBerglundVax explains at #BIOCEO21
2
5